Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-CD274, AHLX-20 Vector   (CAT#: GTVCR-WQ347MR)

This product GTVCR-WQ347MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting CD274. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens; Humanized
RefSeq NM_001267706.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 29126
UniProt ID Q9NZQ7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-CD274, AHLX-20 Vector (GTVCR-WQ347MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2157MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNF, OPRX-106 Vector Vector OPRX-106
GTVCR-WQ496MR IVTScrip™ pT7-VEE-mRNA-Anti-ERBB3, AMG888 Vector Vector AMG888
GTVCR-WQ458MR IVTScrip™ pSP6-VEE-mRNA-Anti-SOST, AMG 785 Vector Vector AMG 785
GTVCR-WQ1207MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-8A-F9Z CAR Vector Vector FMC63 scFv-8A-F9Z CAR
GTVCR-WQ310MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, ADCT-402 Vector Vector ADCT-402
GTVCR-WQ512MR IVTScrip™ pT7-VEE-mRNA-Anti-ITGA4&ITGB7&ITGAE, Anti-Beta7 Vector Vector Anti-Beta7
GTVCR-WQ201MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, ABP 215 Vector Vector ABP 215
GTVCR-WQ1169MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, ESBA-1008 Vector Vector ESBA-1008
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.